<code id='FAF5FB3372'></code><style id='FAF5FB3372'></style>
    • <acronym id='FAF5FB3372'></acronym>
      <center id='FAF5FB3372'><center id='FAF5FB3372'><tfoot id='FAF5FB3372'></tfoot></center><abbr id='FAF5FB3372'><dir id='FAF5FB3372'><tfoot id='FAF5FB3372'></tfoot><noframes id='FAF5FB3372'>

    • <optgroup id='FAF5FB3372'><strike id='FAF5FB3372'><sup id='FAF5FB3372'></sup></strike><code id='FAF5FB3372'></code></optgroup>
        1. <b id='FAF5FB3372'><label id='FAF5FB3372'><select id='FAF5FB3372'><dt id='FAF5FB3372'><span id='FAF5FB3372'></span></dt></select></label></b><u id='FAF5FB3372'></u>
          <i id='FAF5FB3372'><strike id='FAF5FB3372'><tt id='FAF5FB3372'><pre id='FAF5FB3372'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:22638
          Mike Reddy for STAT

          BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy.

          The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars. Rather, they would be receiving a CAR-T brewed up right here at Hospital Clínic de Barcelona.

          advertisement

          Under a special European policy, the CAR-T developed by the hospital’s experts had won regulatory approval in Spain and was reimbursed by the national health system like other authorized medications. The therapy provided another option for patients, all at a price of 89,000 euros ($97,000), roughly a third of the list prices of the CAR-T products from biopharma companies.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more
          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition
          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

          ChristineKao/STATTheFoodandDrugAdministration’sapprovalonFridayoftwogenetherapiesforsicklecelldiseas

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          Medical student insurance fails on mental health care coverage

          OLIVIERDOULIERY/AFPviaGettyImagesMedicalstudentsexperiencesignificantmentaldistress,includinghighrat